Rehwinkel J, Gack MU. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat Rev Immunol. 2020;20:537–51. https://doi.org/10.1038/s41577-020-0288-3.
Article CAS PubMed PubMed Central Google Scholar
Lu C, MacDougall M. RIG-I-like receptor signaling in Singleton-Merten Syndrome. Front Genet. 2017. https://doi.org/10.3389/fgene.2017.00118.
Article PubMed PubMed Central Google Scholar
Özkinay C, Mitelman F. A simple trypsin-Giemsa technique producing simultaneous G- and C-banding in human chromosomes. Hereditas. 1979;90:1–4.
Janetzko K, Rink G, Hecker A, Bieback K, Klüter H, Bugert P. A single-tube real-time PCR assay for Mycoplasma detection as a routine quality control of cell therapeutics. Transfus Med Hemother. 2014;41:83–9. https://doi.org/10.1159/000357096.
Neganova I, Chichagova V, Armstrong L, et al. A critical role for p38MAPK signalling pathway during reprogramming of human fibroblasts to iPSCs. Sci Rep. 2017;7:41693. https://doi.org/10.1038/srep41693.
Article CAS PubMed PubMed Central Google Scholar
Rutsch F, MacDougall M, Lu C, Buers I, Mamaeva O, Nitschke Y, Rice GI, Erlandsen H, Kehl HG, Thiele H, Nürnberg P, Höhne W, Crow YJ, Feigenbaum A, Hennekam RC. A specific IFIH1 gain-of-function mutation causes Singleton-Merten syndrome. Am J Hum Genet. 2015;96(2):275–82. https://doi.org/10.1016/j.ajhg.2014.12.014.
Article CAS PubMed PubMed Central Google Scholar
Rice GI, Park S, Gavazzi F, Adang LA, Ayuk LA, Van Eyck L, Seabra L, Barrea C, Battini R, Belot A, Berg S, Billette de Villemeur T, Bley AE, Blumkin L, Boespflug-Tanguy O, Briggs TA, Brimble E, Dale RC, Darin N, Debray FG, De Giorgis V, Denecke J, Doummar D, Drake Af Hagelsrum G, Eleftheriou D, Estienne M, Fazzi E, Feillet F, Galli J, Hartog N, Harvengt J, Heron B, Heron D, Kelly DA, Lev D, Levrat V, Livingston JH, Marti I, Mignot C, Mochel F, Nougues MC, Oppermann I, Pérez-Dueñas B, Popp B, Rodero MP, Rodriguez D, Saletti V, Sharpe C, Tonduti D, Vadlamani G, Van Haren K, Tomas Vila M, Vogt J, Wassmer E, Wiedemann A, Wilson CJ, Zerem A, Zweier C, Zuberi SM, Orcesi S, Vanderver AL, Hur S, Crow YJ. Genetic and phenotypic spectrum associated with IFIH1 gain-of-function. Hum Mutat. 2020;41(4):837–49. https://doi.org/10.1002/humu.23975.
Article CAS PubMed PubMed Central Google Scholar
Ferreira CR, Crow YJ, Gahl WA, Gardner PJ, Goldbach-Mansky R, Hur S, de Jesús AA, Nehrebecky M, Park JW, Briggs TA. DDX58 and classic Singleton-Merten Syndrome. J Clin Immunol. 2019;39:75–80. https://doi.org/10.1007/s10875-018-0572-1.
Wong C, Gerasimavicius L, Crow YJ, Uggenti C. E794del consortium. MDA5 gain-of-function associated with a Glu794del mutation. J Clin Immunol. 2024;45(1):20. https://doi.org/10.1007/s10875-024-01813-7.
Article CAS PubMed PubMed Central Google Scholar
Lässig C, Lammens K, Gorenflos López JL, Michalski S, Fettscher O, Hopfner KP. Unified mechanisms for self-RNA recognition by RIG-I Singleton-Merten syndrome variants. Elife. 2018;26(7): e38958. https://doi.org/10.7554/eLife.38958.
Jang MA, Kim EK, Now H, Nguyen NT, Kim WJ, Yoo JY, Lee J, Jeong YM, Kim CH, Kim OH, Sohn S, Nam SH, Hong Y, Lee YS, Chang SA, Jang SY, Kim JW, Lee MS, Lim SY, Sung KS, Park KT, Kim BJ, Lee JH, Kim DK, Kee C, Ki CS. Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. Am J Hum Genet. 2015;96:266–74. https://doi.org/10.1016/j.ajhg.2014.11.019.
Article CAS PubMed PubMed Central Google Scholar
Jeong S, Chang H, Hong SH. Protocol for differentiation of functional macrophages from human induced pluripotent stem cells. STAR Protoc. 2024;5(1):102925. https://doi.org/10.1016/j.xpro.2024.102925.
Article CAS PubMed PubMed Central Google Scholar
Jeon O, Panicker L, Lu Q, Chae J, Feldman R, Elisseefet J. Human iPSC-derived osteoblasts and osteoclasts together promote bone regeneration in 3D biomaterials. Sci Rep. 2016;6:26761. https://doi.org/10.1038/srep26761.
Article CAS PubMed PubMed Central Google Scholar
Gu M. Efficient differentiation of human pluripotent stem cells to endothelial cells. Curr Prot Human Genet. 2018. https://doi.org/10.1002/cphg.64.
Comments (0)